VitaVitro Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $15.4M

  • Investors
  • 10

VitaVitro General Information

Description

Developer of assisted reproductive technology intended to solve infertility problem. The company's main business includes the entire process from egg retrieval, freezing, culture to embryo transfer, helping clients get the best quality embryos and increase the pregnancy rate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 601, Building B, Haikexing Strategic Emerging Industrial Park
  • 16 Baoshan Road, Pingshan District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 601, Building B, Haikexing Strategic Emerging Industrial Park
  • 16 Baoshan Road, Pingshan District
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VitaVitro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 07-Sep-2021 $15.4M Completed Generating Revenue
4. Early Stage VC (Series B) 09-Jun-2020 Completed Generating Revenue
3. Early Stage VC (Series A) 14-Jan-2019 Completed Generating Revenue
2. Early Stage VC 13-Oct-2017 Completed Generating Revenue
1. Early Stage VC 17-Aug-2016 Completed Startup
To view VitaVitro’s complete valuation and funding history, request access »

VitaVitro Patents

VitaVitro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202021004064-U1 A cell culture dish Active 02-Jun-2020
EP-3919609-A1 Cell culture dish Inactive 02-Jun-2020
US-20220056386-A1 Cell culture dish Inactive 02-Jun-2020
EP-3760704-A1 Microfluidic chip and microfluidic device for physically and chemically treating single cell, and method for physically and chemically treating single cell by using microfluidic chip and microfluidic device Pending 12-Jun-2018
EP-3760704-A4 Microfluidic chip and microfluidic device for physically and chemically treating single cell, and method for physically and chemically treating single cell by using microfluidic chip and microfluidic device Pending 12-Jun-2018 B01L3/502738
To view VitaVitro’s complete patent history, request access »

VitaVitro Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
CICC Capital PE/Buyout Minority
RFund Venture Capital Minority
Shanghai Zhangjiang Science & Technology Venture Capital Corporate Venture Capital Minority
Dalton Venture Venture Capital Minority
Midas Capital (China) Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

VitaVitro FAQs

  • When was VitaVitro founded?

    VitaVitro was founded in 2015.

  • Where is VitaVitro headquartered?

    VitaVitro is headquartered in Shenzhen, China.

  • What industry is VitaVitro in?

    VitaVitro’s primary industry is Laboratory Services (Healthcare).

  • Is VitaVitro a private or public company?

    VitaVitro is a Private company.

  • What is VitaVitro’s current revenue?

    The current revenue for VitaVitro is .

  • How much funding has VitaVitro raised over time?

    VitaVitro has raised $15.4M.

  • Who are VitaVitro’s investors?

    CICC Capital, RFund, Shanghai Zhangjiang Science & Technology Venture Capital, Dalton Venture, and Midas Capital (China) are 5 of 10 investors who have invested in VitaVitro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »